Risk Communication Regarding Imported Cisatracurium Injection

Due to a shortage of Cisatracurium injection from Omega (Cisatracurium Besylate Injection, 2 mg/mL), Health Canada has permitted the exceptional, temporary importation and sale of Italian-authorized Cisatracurio Hikma 2 mg/mL with Italian-only labels.

The Hikma product (Italian-authorized Cisatracurio Hikma 2 mg/mL) is packaged in 10 mL single-use clear glass ampoules and DOES NOT display “WARNING: PARALYZING AGENT” or “PARALYZING AGENT”.

This health professional risk communication is available in English and French from Health Canada.